1. Two novel prolactin release-inhibiting 8 alpha-amino-ergolines;Fluckiger;Experientia,1979
2. Treatment of Parkinson's disease with 8-alpha-amino-ergoline, CU 32-085;Schneider;Neurology,1983
3. Biphasic influence of 8-alpha-aminoergoline CU 32-085 on striatal dopamine synthesis and turnover in vivo in the rat;Enz;Life Science,1981
4. Central dopamine receptors;Fluckiger;Postgraduate Medical Journal,1981
5. Dopaminergic properties of CU 32-085 and its 1, 20-N-bidemethylated metabolite;Enz;Abstracts of the 13th CINP Congress Jerusalem. Collegium Internationale Psychopharmacologicum,1982